AI assistant
Sending…
Nautilus Biotechnology, Inc. — Director's Dealing 2021
May 24, 2021
34183_dirs_2021-05-24_f2262814-5050-47b2-bf09-4f22d336710e.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 3 — Initial Statement of Beneficial Ownership
Issuer: ARYA Sciences Acquisition Corp III (ARYA)
CIK: 0001808805
Period of Report: 2021-05-20
Reporting Person: PERCEPTIVE ADVISORS LLC (Director)
Reporting Person: PERCEPTIVE LIFE SCIENCES MASTER FUND LTD (Director)